Proliferation and Angiogenesis Using Immunohistochemistry in Prognosticating Multiple Myeloma
Open Access
- 19 January 2016
- journal article
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 32 (4) , 418-423
Abstract
Multiple myeloma is a neoplasm of plasma cells characterised by the presence of M protein in serum and urine. Angiogenesis and proliferation play a major role in the pathogenesis of various neoplasms. The study evaluated proliferation and angiogenesis in 48 cases of myeloma, and correlated it with morphological and clinical parameters. The histomorphological features like plasma cell morphology, percentage of plasma cells and pattern of infiltration were studied in the bone marrow aspirate and trephine biopsy. Angiogenesis was assessed by calculating the microvessel density (MVD) using immunohistochemistry for CD34. Proliferation was assessed using Ki67 and CD38 highlighted the plasma cells. The mean Ki67 % was found to be significantly higher (19.6 % range 2–40 %) in poorly differentiated morphology compared to well differentiated morphology (4.06 % range 0.2–20 %) (p = 0.003). The mean MVD in the well differentiated morphology was 10.6 (range 1.2–47.4) compared to 20.3 (range 6.9–39.6) in the poorly differentiated morphology (p = 0.04). The mean MVD was 5.7 (range 1.2–12.8) in the interstitial pattern of infiltration compared to 20.04 (2.9–47.4) in the diffuse pattern (p < 0.0001). The mean MVD was 6.4 in cases with serum albumin >3.5 gm/dl compared to 13.3 in cases with serum albumin p = 0.009). Both the Ki67 and MVD showed an increasing trend with the clinical staging. Thus the study of proliferation and angiogenesis in bone marrow biopsy is useful for prognosticating patients with multiple myeloma.Keywords
This publication has 14 references indexed in Scilit:
- Immunohistochemical expression of endoglin offers a reliable estimation of bone marrow neoangiogenesis in multiple myelomaJournal of Cancer Research and Clinical Oncology, 2015
- International Staging System for Multiple MyelomaJournal of Clinical Oncology, 2005
- Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesisHistopathology, 2005
- The relation between bone marrow angiogenesis and the proliferation index Ki-67 in multiple myelomaJournal of Clinical Pathology, 2004
- Risk Groups of Myeloma Patients by Histologic Pattern and Proliferative ActivityAmerican Journal of Surgical Pathology, 1997
- Prognostic relevance of a histologic classification system applied in bone marrow biopsies from patients with multiple myeloma: A histopathological evaluation of biopsies from 153 untreated patients*European Journal of Haematology, 1995
- Bone marrow angiogenesis and progression in multiple myelomaBritish Journal of Haematology, 1994
- Interleukin-6 in Multiple Myeloma: Correlation with Disease Activity and Ki-67 Proliferation IndexLeukemia & Lymphoma, 1994
- Biology and treatment of multiple myelomaBlood Reviews, 1993
- The biological and clinical significance of the KI‐67 growth fraction in multiple myelomaHematological Oncology, 1992